Cannabis use in patients with gastroparesis increased and was associated with increased odds of emergency department (ED) visits and hospitalizations but reduced esophagogastroduodenoscopy rates. To ...
IFFGD will raise awareness for Gastroparesis during August to shed light on those impacted and how to advocate as a community Gastroparesis, also called delayed gastric emptying, is a chronic ...
Please provide your email address to receive an email when new articles are posted on . Every August, gastrointestinal care providers and patient advocacy groups celebrate Gastroparesis Awareness ...
1mon
Influencer With Stomach Paralysis Says Her Condition Isn’t Due to GLP-1: ‘Nothing I Did to Myself’
TikToker Shayla Talei is setting the record straight about her stomach condition. The influencer, 31, who has been diagnosed ...
Please provide your email address to receive an email when new articles are posted on . Noninvasive vagal nerve stimulation reduced the number of rescue medications used by half. Stimulation also ...
In her viral social media videos, Shayla Talei explains what her daily routine looks like living with multiple debilitating ...
Ducharme is a contributor to TIME. Ducharme is a contributor to TIME. In 2021, Jacqueline Barber agreed to try Ozempic because her doctor swore it would “work wonders” for her diabetes. A few months ...
Gastroparesis is a chronic disorder that affects a significant subset of the population. Diabetes mellitus is a risk factor for the development of gastroparesis. Currently, metoclopramide is the only ...
A recent study published by the Journal of the American Medical Association (JAMA) found that patients taking the drugs Ozempic (semaglutide) and Wegovy (liraglutide) for weight loss were more than ...
Tradipitant is set to capitalize on key market opportunities including its novel mechanism for treating nausea, potential as an adjunct in the growing GLP-1 market, prospects in gastroparesis pending ...
A PDUFA target date of September 18, 2024 has been set for the application. The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for tradipitant for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results